{"id":45263,"date":"2022-06-20T16:01:35","date_gmt":"2022-06-20T14:01:35","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/global-antisense-rnai-therapeutics-market-research-report-2022-technology-route-indication-analysis-forecasts-2016-2021-2021-2026f-2031f-researchandmarkets-com\/"},"modified":"2022-06-20T16:01:35","modified_gmt":"2022-06-20T14:01:35","slug":"global-antisense-rnai-therapeutics-market-research-report-2022-technology-route-indication-analysis-forecasts-2016-2021-2021-2026f-2031f-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/global-antisense-rnai-therapeutics-market-research-report-2022-technology-route-indication-analysis-forecasts-2016-2021-2021-2026f-2031f-researchandmarkets-com\/","title":{"rendered":"Global Antisense &amp; RNAi Therapeutics Market Research Report 2022: Technology, Route, Indication Analysis &amp; Forecasts, 2016-2021, 2021-2026F, 2031F &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5553743\/antisense-and-rnai-therapeutics-global-market?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=43kb4m&amp;utm_campaign=1716003+-+Global+Antisense+%26+RNAi+Therapeutics+Market+Research+Report+2022%3A+Technology%2C+Route%2C+Indication+Analysis+%26+Forecasts%2C+2016-2021%2C+2021-2026F%2C+2031F&amp;utm_exec=chdo54prd\" rel=\"nofollow noopener\" shape=\"rect\">&#8220;Antisense &amp; RNAi Therapeutics Global Market Report 2022: By Technology, By Route, By Indication&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220620005363\/en\/1491153\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220620005363\/en\/1491153\/21\/logo.jpg\"><\/a><\/p>\n<p>\nThe global antisense &amp; RNAI therapeutics market is expected to grow from $1.32 billion in 2021 to $1.42 billion in 2022 at a compound annual growth rate (CAGR) of 8%. The market is expected to reach $2.14 billion in 2026 at a CAGR of 10.8%.\n<\/p>\n<p>\nMajor players in the antisense &amp; RNAi therapeutics market are Alnylam Pharmaceuticals, Benitec Biopharma Ltd., Gene Signal, GlaxoSmithKline Plc, Ionis Pharmaceuticals, Marina Biosciences, Quark Pharmaceuticals, Sanofi S.A, Acuitas Therapeutics and Antisense Therapeutics Ltd.\n<\/p>\n<p>\nThe antisense &amp; RNAi therapeutics market consists of sales of antisense &amp; RNAi therapeutics products and related services by entities (organizations, sole traders and partnerships) that develop antisense &amp; RNAi therapeutics to treat various diseases. RNA interference (RNAi)-based and RNA-based antisense oligonucleotide therapies are advanced methods used for the treatment of various respiratory diseases including chronic obstructive pulmonary disease (COPD) and asthma. In addition to this, antisense &amp; RNAi therapeutics finds its application in curing cancer, infectious diseases, cardiovascular diseases, and genetic disorders.\n<\/p>\n<p>\nThe main technologies of antisense &amp; RNAi therapeutics are RNA interference, antisense RNA. RNA interference is a conserved biological response to double-stranded RNA that mediates resistance to both endogenous parasitic and exogenous pathogenic nucleic acids and regulates protein-coding gene expression.\n<\/p>\n<p>\nThe various route of administration include pulmonary delivery, intravenous injections, intra-dermal injections, intraperitoneal injections, topical delivery, other delivery methods that are used for the indication of oncology, cardiovascular diseases (CVDs), respiratory disorders, neurological disorders, infectious diseases, other.\n<\/p>\n<p>\nThe rising prevalence of coronary artery diseases, neurodegenerative disorders, and infectious diseases is projected to contribute to the demand for the antisense &amp; RNAi therapeutics market. Gene suppression approaches including RNA interference and antisense oligonucleotides are used for the treatment of various neurodegenerative conditions by repairing mutant genes.\n<\/p>\n<p>\nAccording to the National Institute of Environmental Health Sciences, Alzheimer&#8217;s disease and Parkinson&#8217;s disease are the most common neurodegenerative diseases affecting millions of people globally. In the USA, around 930,000 people had Parkinson&#8217;s disease by the end of 2020. Hence, the growing prevalence of several neurodegenerative diseases and infectious diseases is expected to drive the growth of the antisense &amp; RNAi therapeutics market.\n<\/p>\n<p>\nThe high cost of RNA interference-based drugs is expected to act as a major restraint for the growth of the antisense &amp; RNAi therapeutics market in the future. For instance, according to Future Medicine, the price of Onpattro is approximately $450,000 per year. Onpattro (patisaran) is the RNA interference-based drug used for the treatment of the polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis in adults.\n<\/p>\n<p>\nStringent regulations, long product approval process, high development cost, and a comparably small number of patients are few factors leading to the high cost of RNA interference drugs, which is expected to hinder the antisense &amp; RNAi therapeutics&#8217; market growth in upcoming years.\n<\/p>\n<p>\nMajor companies operating in the antisense &amp; RNAi therapeutics market are undertaking strategic initiatives such as collaborations and partnerships for product innovation to sustain in the increasingly competitive market, companies are developing innovative products as well as sharing skills and expertise with other companies.\n<\/p>\n<p>\nWhile companies have long collaborated with each other as well as with academic and research institutions in this market by way of partnerships, and in or out-licensing deals, this trend has been increasing over recent years.\n<\/p>\n<p>\n<strong>Companies Featured<\/strong>\n<\/p>\n<ul>\n<li>\nAlnylam Pharmaceuticals\n<\/li>\n<li>\nBenitec Biopharma Ltd.\n<\/li>\n<li>\nGene Signal\n<\/li>\n<li>\nGlaxoSmithKline plc.\n<\/li>\n<li>\nIonis Pharmaceuticals\n<\/li>\n<li>\nMarina Biosciences\n<\/li>\n<li>\nQuark Pharmaceuticals\n<\/li>\n<li>\nSanofi S.A\n<\/li>\n<li>\nAcuitas Therapeutics\n<\/li>\n<li>\nAntisense Therapeutics Ltd.\n<\/li>\n<li>\nArbutus Biopharma (formerly known as Tekmira Pharmaceuticals)\n<\/li>\n<li>\nBio-Path Holdings inc.\n<\/li>\n<li>\nCalando Pharmaceuticals\n<\/li>\n<li>\nDicerna Pharmaceuticals\n<\/li>\n<li>\nEnzon Pharmaceuticals inc.\n<\/li>\n<li>\nGradalis\n<\/li>\n<li>\niCo Therapeutics\n<\/li>\n<li>\nmiRagen Therapeutics\n<\/li>\n<li>\nOlix Pharmaceuticals\n<\/li>\n<li>\nOncoGeneX Pharmaceuticals\n<\/li>\n<li>\nLorus Therapeutics (Aptose Biosciences)\n<\/li>\n<li>\nRegulus Therapeutics\n<\/li>\n<li>\nRexahn Pharmaceuticals\n<\/li>\n<li>\nRxi Pharmaceuticals\n<\/li>\n<li>\nSantaris Pharma A\/S (Roche)\n<\/li>\n<li>\nSarepta Therapeutics\n<\/li>\n<li>\nSilence Therapeutics plc.\n<\/li>\n<li>\nSirnaomics inc.\n<\/li>\n<li>\nTekmira Pharmaceuticals\n<\/li>\n<li>\nCenix BioScience\n<\/li>\n<li>\nSirnaomics\n<\/li>\n<\/ul>\n<p>\n<strong>Key Topics Covered:<\/strong>\n<\/p>\n<p>\n<strong>1. Executive Summary<\/strong>\n<\/p>\n<p>\n<strong>2. Antisense &amp; RNAi Therapeutics Market Characteristics<\/strong>\n<\/p>\n<p>\n<strong>3. Antisense &amp; RNAi Therapeutics Market Trends And Strategies<\/strong>\n<\/p>\n<p>\n<strong>4. Impact Of COVID-19 On Antisense &amp; RNAi Therapeutics<\/strong>\n<\/p>\n<p>\n<strong>5. Antisense &amp; RNAi Therapeutics Market Size And Growth<\/strong>\n<\/p>\n<p>\n5.1. Global Antisense &amp; RNAi Therapeutics Historic Market, 2016-2021, $ Billion\n<\/p>\n<p>\n5.1.1. Drivers Of The Market\n<\/p>\n<p>\n5.1.2. Restraints On The Market\n<\/p>\n<p>\n5.2. Global Antisense &amp; RNAi Therapeutics Forecast Market, 2021-2026F, 2031F, $ Billion\n<\/p>\n<p>\n5.2.1. Drivers Of The Market\n<\/p>\n<p>\n5.2.2. Restraints On the Market\n<\/p>\n<p>\n<strong>6. Antisense &amp; RNAi Therapeutics Market Segmentation<\/strong>\n<\/p>\n<p>\n6.1. Global Antisense &amp; RNAi Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion\n<\/p>\n<ul>\n<li>\nRNA Interference\n<\/li>\n<li>\nAntisense RNA\n<\/li>\n<\/ul>\n<p>\n6.2. Global Antisense &amp; RNAi Therapeutics Market, Segmentation By Route of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion\n<\/p>\n<ul>\n<li>\nPulmonary Delivery\n<\/li>\n<li>\nIntravenous Injections\n<\/li>\n<li>\nIntra-dermal Injections\n<\/li>\n<li>\nIntraperitoneal Injections\n<\/li>\n<li>\nTopical Delivery\n<\/li>\n<li>\nOther Delivery Methods\n<\/li>\n<\/ul>\n<p>\n6.3. Global Antisense &amp; RNAi Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion\n<\/p>\n<ul>\n<li>\nOncology\n<\/li>\n<li>\nCardiovascular Diseases (CVDs)\n<\/li>\n<li>\nRespiratory Disorders\n<\/li>\n<li>\nNeurological Disorders\n<\/li>\n<li>\nInfectious Diseases\n<\/li>\n<li>\nOther\n<\/li>\n<\/ul>\n<p>\n<strong>7. Antisense &amp; RNAi Therapeutics Market Regional And Country Analysis<\/strong>\n<\/p>\n<p>\n7.1. Global Antisense &amp; RNAi Therapeutics Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion\n<\/p>\n<p>\n7.2. Global Antisense &amp; RNAi Therapeutics Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion\n<\/p>\n<p>\n<strong>8. Asia-Pacific Antisense &amp; RNAi Therapeutics Market<\/strong>\n<\/p>\n<p>\n8.1. Asia-Pacific Antisense &amp; RNAi Therapeutics Market Overview\n<\/p>\n<ul>\n<li>\nRegion Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies\n<\/li>\n<\/ul>\n<p>\n8.2. Asia-Pacific Antisense &amp; RNAi Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion\n<\/p>\n<p>\n8.3. Asia-Pacific Antisense &amp; RNAi Therapeutics Market, Segmentation By Route of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion\n<\/p>\n<p>\n<strong>9. China Antisense &amp; RNAi Therapeutics Market<\/strong>\n<\/p>\n<p>\n<strong>10. India Antisense &amp; RNAi Therapeutics Market<\/strong>\n<\/p>\n<p>\n<strong>11. Japan Antisense &amp; RNAi Therapeutics Market<\/strong>\n<\/p>\n<p>\n<strong>12. Australia Antisense &amp; RNAi Therapeutics Market<\/strong>\n<\/p>\n<p>\n<strong>13. Indonesia Antisense &amp; RNAi Therapeutics Market<\/strong>\n<\/p>\n<p>\n<strong>14. South Korea Antisense &amp; RNAi Therapeutics Market<\/strong>\n<\/p>\n<p>\n<strong>15. Western Europe Antisense &amp; RNAi Therapeutics Market<\/strong>\n<\/p>\n<p>\n<strong>16. UK Antisense &amp; RNAi Therapeutics Market<\/strong>\n<\/p>\n<p>\n<strong>17. Germany Antisense &amp; RNAi Therapeutics Market<\/strong>\n<\/p>\n<p>\n<strong>18. France Antisense &amp; RNAi Therapeutics Market<\/strong>\n<\/p>\n<p>\n<strong>19. Eastern Europe Antisense &amp; RNAi Therapeutics Market<\/strong>\n<\/p>\n<p>\n<strong>20. Russia Antisense &amp; RNAi Therapeutics Market<\/strong>\n<\/p>\n<p>\n<strong>21. North America Antisense &amp; RNAi Therapeutics Market<\/strong>\n<\/p>\n<p>\n<strong>22. USA Antisense &amp; RNAi Therapeutics Market<\/strong>\n<\/p>\n<p>\n<strong>23. South America Antisense &amp; RNAi Therapeutics Market<\/strong>\n<\/p>\n<p>\n<strong>24. Brazil Antisense &amp; RNAi Therapeutics Market<\/strong>\n<\/p>\n<p>\n<strong>25. Middle East Antisense &amp; RNAi Therapeutics Market<\/strong>\n<\/p>\n<p>\n<strong>26. Africa Antisense &amp; RNAi Therapeutics Market<\/strong>\n<\/p>\n<p>\n<strong>27. Antisense &amp; RNAi Therapeutics Market Competitive Landscape And Company Profiles<\/strong>\n<\/p>\n<p>\n27.1. Antisense &amp; RNAi Therapeutics Market Competitive Landscape\n<\/p>\n<p>\n27.2. Antisense &amp; RNAi Therapeutics Market Company Profiles\n<\/p>\n<p>\n<strong>28. Antisense &amp; RNAi Therapeutics Pipeline Analysis<\/strong>\n<\/p>\n<p>\n<strong>29. Key Mergers And Acquisitions In The Antisense &amp; RNAi Therapeutics Market<\/strong>\n<\/p>\n<p>\n<strong>30. Antisense &amp; RNAi Therapeutics Market Future Outlook and Potential Analysis<\/strong>\n<\/p>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5553743\/antisense-and-rnai-therapeutics-global-market?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=43kb4m&amp;utm_campaign=1716003+-+Global+Antisense+%26+RNAi+Therapeutics+Market+Research+Report+2022%3A+Technology%2C+Route%2C+Indication+Analysis+%26+Forecasts%2C+2016-2021%2C+2021-2026F%2C+2031F&amp;utm_exec=chdo54prd\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/q4hkt1<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#x61;&#x69;l&#116;&#x6f;:&#112;&#x72;&#x65;s&#115;&#x40;r&#101;&#x73;&#x65;a&#114;&#x63;h&#97;&#x6e;&#x64;&#109;&#97;&#x72;k&#101;&#x74;&#x73;&#46;&#x63;&#x6f;m\" rel=\"nofollow noopener\" shape=\"rect\">&#112;r&#x65;s&#x73;&#64;&#x72;e&#x73;e&#x61;r&#x63;&#104;&#x61;&#110;&#x64;&#109;&#x61;&#114;&#x6b;&#101;&#x74;&#115;&#x2e;&#99;o&#x6d;<\/a><br \/>For E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Antisense &amp; RNAi Therapeutics Global Market Report 2022: By Technology, By Route, By Indication&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The global antisense &amp; RNAI therapeutics market is expected to grow from $1.32 billion in 2021 to $1.42 billion in 2022 at a compound annual growth rate (CAGR) of 8%. The market &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/global-antisense-rnai-therapeutics-market-research-report-2022-technology-route-indication-analysis-forecasts-2016-2021-2021-2026f-2031f-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-45263","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Global Antisense &amp; RNAi Therapeutics Market Research Report 2022: Technology, Route, Indication Analysis &amp; Forecasts, 2016-2021, 2021-2026F, 2031F - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/global-antisense-rnai-therapeutics-market-research-report-2022-technology-route-indication-analysis-forecasts-2016-2021-2021-2026f-2031f-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Global Antisense &amp; RNAi Therapeutics Market Research Report 2022: Technology, Route, Indication Analysis &amp; Forecasts, 2016-2021, 2021-2026F, 2031F - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Antisense &amp; RNAi Therapeutics Global Market Report 2022: By Technology, By Route, By Indication&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The global antisense &amp; RNAI therapeutics market is expected to grow from $1.32 billion in 2021 to $1.42 billion in 2022 at a compound annual growth rate (CAGR) of 8%. The market ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/global-antisense-rnai-therapeutics-market-research-report-2022-technology-route-indication-analysis-forecasts-2016-2021-2021-2026f-2031f-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-06-20T14:01:35+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220620005363\/en\/1491153\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-antisense-rnai-therapeutics-market-research-report-2022-technology-route-indication-analysis-forecasts-2016-2021-2021-2026f-2031f-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-antisense-rnai-therapeutics-market-research-report-2022-technology-route-indication-analysis-forecasts-2016-2021-2021-2026f-2031f-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Global Antisense &amp; RNAi Therapeutics Market Research Report 2022: Technology, Route, Indication Analysis &amp; Forecasts, 2016-2021, 2021-2026F, 2031F &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2022-06-20T14:01:35+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-antisense-rnai-therapeutics-market-research-report-2022-technology-route-indication-analysis-forecasts-2016-2021-2021-2026f-2031f-researchandmarkets-com\\\/\"},\"wordCount\":1147,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-antisense-rnai-therapeutics-market-research-report-2022-technology-route-indication-analysis-forecasts-2016-2021-2021-2026f-2031f-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220620005363\\\/en\\\/1491153\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-antisense-rnai-therapeutics-market-research-report-2022-technology-route-indication-analysis-forecasts-2016-2021-2021-2026f-2031f-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-antisense-rnai-therapeutics-market-research-report-2022-technology-route-indication-analysis-forecasts-2016-2021-2021-2026f-2031f-researchandmarkets-com\\\/\",\"name\":\"Global Antisense &amp; RNAi Therapeutics Market Research Report 2022: Technology, Route, Indication Analysis &amp; Forecasts, 2016-2021, 2021-2026F, 2031F - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-antisense-rnai-therapeutics-market-research-report-2022-technology-route-indication-analysis-forecasts-2016-2021-2021-2026f-2031f-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-antisense-rnai-therapeutics-market-research-report-2022-technology-route-indication-analysis-forecasts-2016-2021-2021-2026f-2031f-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220620005363\\\/en\\\/1491153\\\/21\\\/logo.jpg\",\"datePublished\":\"2022-06-20T14:01:35+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-antisense-rnai-therapeutics-market-research-report-2022-technology-route-indication-analysis-forecasts-2016-2021-2021-2026f-2031f-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-antisense-rnai-therapeutics-market-research-report-2022-technology-route-indication-analysis-forecasts-2016-2021-2021-2026f-2031f-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-antisense-rnai-therapeutics-market-research-report-2022-technology-route-indication-analysis-forecasts-2016-2021-2021-2026f-2031f-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220620005363\\\/en\\\/1491153\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220620005363\\\/en\\\/1491153\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-antisense-rnai-therapeutics-market-research-report-2022-technology-route-indication-analysis-forecasts-2016-2021-2021-2026f-2031f-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Global Antisense &amp; RNAi Therapeutics Market Research Report 2022: Technology, Route, Indication Analysis &amp; Forecasts, 2016-2021, 2021-2026F, 2031F &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Global Antisense &amp; RNAi Therapeutics Market Research Report 2022: Technology, Route, Indication Analysis &amp; Forecasts, 2016-2021, 2021-2026F, 2031F - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/global-antisense-rnai-therapeutics-market-research-report-2022-technology-route-indication-analysis-forecasts-2016-2021-2021-2026f-2031f-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"Global Antisense &amp; RNAi Therapeutics Market Research Report 2022: Technology, Route, Indication Analysis &amp; Forecasts, 2016-2021, 2021-2026F, 2031F - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Antisense &amp; RNAi Therapeutics Global Market Report 2022: By Technology, By Route, By Indication&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The global antisense &amp; RNAI therapeutics market is expected to grow from $1.32 billion in 2021 to $1.42 billion in 2022 at a compound annual growth rate (CAGR) of 8%. The market ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/global-antisense-rnai-therapeutics-market-research-report-2022-technology-route-indication-analysis-forecasts-2016-2021-2021-2026f-2031f-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2022-06-20T14:01:35+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220620005363\/en\/1491153\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/global-antisense-rnai-therapeutics-market-research-report-2022-technology-route-indication-analysis-forecasts-2016-2021-2021-2026f-2031f-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/global-antisense-rnai-therapeutics-market-research-report-2022-technology-route-indication-analysis-forecasts-2016-2021-2021-2026f-2031f-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Global Antisense &amp; RNAi Therapeutics Market Research Report 2022: Technology, Route, Indication Analysis &amp; Forecasts, 2016-2021, 2021-2026F, 2031F &#8211; ResearchAndMarkets.com","datePublished":"2022-06-20T14:01:35+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/global-antisense-rnai-therapeutics-market-research-report-2022-technology-route-indication-analysis-forecasts-2016-2021-2021-2026f-2031f-researchandmarkets-com\/"},"wordCount":1147,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/global-antisense-rnai-therapeutics-market-research-report-2022-technology-route-indication-analysis-forecasts-2016-2021-2021-2026f-2031f-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220620005363\/en\/1491153\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/global-antisense-rnai-therapeutics-market-research-report-2022-technology-route-indication-analysis-forecasts-2016-2021-2021-2026f-2031f-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/global-antisense-rnai-therapeutics-market-research-report-2022-technology-route-indication-analysis-forecasts-2016-2021-2021-2026f-2031f-researchandmarkets-com\/","name":"Global Antisense &amp; RNAi Therapeutics Market Research Report 2022: Technology, Route, Indication Analysis &amp; Forecasts, 2016-2021, 2021-2026F, 2031F - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/global-antisense-rnai-therapeutics-market-research-report-2022-technology-route-indication-analysis-forecasts-2016-2021-2021-2026f-2031f-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/global-antisense-rnai-therapeutics-market-research-report-2022-technology-route-indication-analysis-forecasts-2016-2021-2021-2026f-2031f-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220620005363\/en\/1491153\/21\/logo.jpg","datePublished":"2022-06-20T14:01:35+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/global-antisense-rnai-therapeutics-market-research-report-2022-technology-route-indication-analysis-forecasts-2016-2021-2021-2026f-2031f-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/global-antisense-rnai-therapeutics-market-research-report-2022-technology-route-indication-analysis-forecasts-2016-2021-2021-2026f-2031f-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/global-antisense-rnai-therapeutics-market-research-report-2022-technology-route-indication-analysis-forecasts-2016-2021-2021-2026f-2031f-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220620005363\/en\/1491153\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220620005363\/en\/1491153\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/global-antisense-rnai-therapeutics-market-research-report-2022-technology-route-indication-analysis-forecasts-2016-2021-2021-2026f-2031f-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Global Antisense &amp; RNAi Therapeutics Market Research Report 2022: Technology, Route, Indication Analysis &amp; Forecasts, 2016-2021, 2021-2026F, 2031F &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/45263","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=45263"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/45263\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=45263"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=45263"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=45263"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}